Induction of Paclitaxel Resistance by the Kaposi's Sarcoma-Associated Herpesvirus Latent Protein LANA2

Kaposi's sarcoma-associated herpesvirus (KSHV) is the causal agent of both KS and primary effusion lymphoma (PEL). Although treatment with paclitaxel has significant antitumor activity in KS, drug resistance represents a major obstacle for improving the overall response and survival of PEL pati...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Muñoz-Fontela, C., Marcos-Villar, L., Hernandez, F., Gallego, P., Rodriguez, E., Arroyo, J., Gao, S.-J., Avila, J., Rivas, C.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology (ASM) 2008
Assuntos:
Transformation and Oncogenesis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2224414/
https://ncbi.nlm.nih.gov/pubmed/18032494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01704-07
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares